Diazoxide enhances adipose tissue protein kinase B activation and gluclose transporter-4 expression in obese Zucker rats

Medical Science Monitor

Volumn 10, Issue 3, 2004, Pages

  Alemzadeh, Ramin ^a   Zhang, Jian ^b   Tushaus, Kathryn ^a   Koontz, John ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Diazoxide; Glucose transport; Glut 4; Hyperinsulinemia; Obesity

Indexed keywords

DIAZOXIDE; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; PROTEIN KINASE B;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; FEMALE; HYPERINSULINEMIA; INSULIN RESPONSE; INSULIN SENSITIVITY; NONHUMAN; OBESITY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RAT STRAIN; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; ANIMALS; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; BLOTTING, NORTHERN; CELL MEMBRANE; DIAZOXIDE; ENZYME ACTIVATION; FEMALE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; INSULIN; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, ZUCKER; RNA; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TIME FACTORS; VASODILATOR AGENTS;

EID: 1542511327     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Bray GA, York DA: Hypothalamic and genetic obesity in experimental animals. An autonomic endocrine hypothesis. Physiol Rev, 1979; 59: 719-809
2. Le Marchand Y, Freychet P, Jeanreneaud B: Longitudinal study on the establishment of insulin resistance in hypothalamic obese mice. Endocrinology, 1985; 102: 74-85
3. Karam JH, Grodsky GM, Forsham PH: Excessive insulin response to glucose in obese subjects as measured by immunochemical assay. Diabetes, 1963; 12: 196-204
4. Polonsky KS, Given BD, Van Cauter E: Twenty-four-hour profiles and pulsatile patterns of insuin secretion in normal and obese subjects. J Clin Invest, 1988; 81: 442-48
5. Bogardus C, Lillioja S, Mott D et al: Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians. J Clin Invest, 1984; 73: 800-05
6. Terretaz J, Jeanreneaud B: In vivo hepatic and peripheral insulin resistance in genetically obese (fa/fa) rats. Endocrinology, 1987; 112: 1346-51
7. Rohner-Jeanreneaud F, Proletto J, Ionescu E, Jeanreneaud B: Mechanism of abnormal glucose tolerance of genetically obese fa/fa rats. Diabetes, 1986; 35: 1350-55
8. Crettaz M, Prentki M, Zaninetti D, Jeanreneaud B: Insulin resistance in soleus muscle from obese Zucker rats: involvement of several defective sites. Biochem J, 1980; 186: 525-34
9. Pessin JE, Bell GI: Mammalian facilitative glucose transporter family: structure and molecular regulation. Ann Rev Physiol, 1992; 54: 911-30
10. McGowan KM, Long, SD, Pekala PH: Glucose transporter gene expression: regulation of transcription and mRNA stability. Pharmac Ther, 1995; 66: 465-505
11. Garvey WT, Maianu L, Huecksteadt TP et al: Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity. J Clin Invest, 1991; 87: 1072-81
12. Sinha MK, Rainen'-Maldonado C, Buchanan C et al: Decreased expression of glucose transporter in muscle from insulin-resistant patients. Am J Physiol, 1991; 260: E459-63
13. Slieker LJ, Sundell KL, Heath WF et al: Glucose transporter levels in tissues of spontaneously diabetic Zucker fa/fa rat (ZDF/drt) and viable yellow mouse (AaY/a): Diabetes, 1992; 41: 187-93
14. Viramaki A, Ueki K, Kahn CR: Protein-protein interactions in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest, 1999; 103: 931-43
15. Okada T, Kawano Y, Sakakibara T et al: Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. J Biol Chem, 1994; 269: 3568-73
16. Cheatham B, Vlahos CJ, Cheatham L et al: Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biochem, 1994; 14: 4902-11
17. Carvalho E, Rondinone C, Smith U: Insulin resistance in fat cells from Zucker rats: Evidence for an impaired activation and translocation of protein kinase B and glucose transporter 4. Mol Cell Biochem, 2000; 206: 7-16
18. Hevener AL, Reichart D, Olefsky J: Exercise and thiazolidinedione therapy normalize insulin action in the obese Zucker fatty rat. Diabetes, 2000; 49: 2154-59
19. Alemzadeh R, Slonim AE, Zdanowicz MM, Maturo J. Modification of insulin resistance by Diazoxide in obese Zucker rats Endocrinology, 1993; 133: 705-12
20. Alemzadeh R, Jacobs W, Pitukcheewanont P: Antiobesity effect of Diazoxide in obese Zucker rats: Metabolism, 1996; 45: 334-41
21. Pedersen O, Hjollund E, Beck-Nielsen Hlidskov HO et al: Insulin receptor binding and receptor mediated insulin degradation in human adipocytes. Diabetologia, 1981; 20: 636-41
22. Lorch E, Rentsch G: A simple method for staining and counting isolated adipose tissue fat cells. Diabetologia, 1969; 5: 356-57
23. Hirsch E, Rentsch G: Methods for determinations of adipose cell size and cell number in man and animals. J Lipid Res, 1968; 9: 110-19
24. Chomczynski, P, Sacchi, N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem, 1978; 162: 156-59
25. Chomczynski, P: Solubilization in formamide protects RNA from degradation. Nucleic Acids Research, 1992; 20: 3791-92
26. Moore PS, Koontz J: Regulation of tyrosine aminotransferase by insulin and cAMP: similar effects on activity but opposite effects on transcription Molecular Endocrinology, 1989; 3: 1724-32
27. McKeel DW, Jarett L: Preparation and characterization of a plasma membrane fraction from isolated fat cells. J Cell Biol, 1970; 44: 417-38
28. Garvey TW, Huecksteadt TP, Matthaei S, Olefsky JM: Role of glucose transporters in the cellular insulin resistance of Type II non-insulin-dependent diabetes mellitus. J Clin Invest, 1988; 81: 1528-36
29. Pedersen O, Kahn CR, Kahn BB: Divergent Regulation of the Glut-1 and Glut-4 Glucose Transporters in Isolated Adipocytes from Zucker Rats. J Clin Invest, 1992; 89: 1964-73
30. Kim S-S, Bae JW, Jung CY: Glut4 degradation rate: reduction in rat adipocytes in fasting and streptozotocin-induced diabetes. Am J Physiol, 1994; 267: E132-E139
31. Klip A, Tsakiridis T, Marette A, Ortiz PA: Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures FASEB. 1994; 8: 43-53
32. Postic C, Leturque A, Rencurel F et al: The effects of hyperinsulinernia on Glut4 and HKII mRNA and protein in rat skeletal muscle and adipose tissue. Diabetes, 1993; 42: 922-29
33. Cusin I, Terrettaz J, Rohner-Jeanrenaud F et al: Hyperinsulinemia increases the amount of Glut4 mRNA in white adipose tissue and decreases that of muscles: a clue for increased fat depot and insulin resistance. Endocrinology, 1990; 127: 3246-48
34. Flores-Riveros JR, McLenithan JC, Ezaki O, Lane MD: Insulin down-regulates expression of the insulin-responsive glucose transporter (Glut4) gene: effects on transcription and mRNA turnover. Proc Natl Acad Sci, 1993; 90: 512-16
35. Petersen S, Bahr M, Eckel J: Insulin-dependent regulation of Glut4 gene expression in ventricular cardiomyocytes: evidence for a direct effect on Glut4 transcription. Biochim. Biophys. Research Comm, 1995; 213: 533-40
36. Jhun BH, Rampal AL, Liu H et al: Effects of insulin on steady state kinetics of Glut4 subcellular distribution in rat adipocytes. J Biol Chem, 1992; 267: 17710-15
37. Anai M, Funaki M, Ogihara T et al: Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substyrates 1 and 2 in Zucker fatty rats. Diabetes, 1998; 47: 1323-28
38. Henquin JC, Meissner HP: Opposite effects of tolbutamide and diazoxide on 86 Rb+ fluxes and membrane potential in pancreatic B cells. Biochem Pharmacol, 1982; 31: 1407-15
39. Antoine MH, Pirotte B, Hermann M et al: Cationic and secretory effects of BPDZ 44 and diazoxide in rat pancreatic islets. Experientia, 1994; 50: 830-32
40. Jacobs DB, Jung CY: Sulfonylurea potentiates insulin-induced recruitment of glucose transport carrier in rat adipocytes. J Biol Chem, 1985; 260: 2593-96
41. Jacobs DB, Hayes GR, Lockwood DH: Effect of chlorpropamide on glucose transport in rat adipocytes in the absence of changes in insulin binding and receptor-associated tyrosine kinase activity. Metabolism, 1987; 36: 548-54
42. Muller G, Weid S. The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin-resistant rat adipocytes in vitro. Diabetes, 1993; 42: 1852-67
43. Bahr M, Holtey MV, Muller G, Eckel, J: Direct stimulation of myocardial glucose transport and glucose transporter-1 (Glut-1) and Glut4 protein expression by the sulfonylurea glimepiride. Endocrinology, 1995; 136: 2547-53
44. Begum N, Leitner W, Reusch JEB et al: GLUT-4 phosphorylation and its intrinsic activity. J Bio Chem, 1993; 268: 3352-56